This randomized clinical trial evaluates the safety and efficacy of two chloroquine diphosphate dosages in patients with severe coronavirus disease 2019 (COVID-19).
Source: Effect of high vs. low dosage of chloroquine diphosphate on SARS-CoV-2 infection